Adrenal incidentalomas

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Abstract. Recent widespread use of radiation research methods has led to more frequent detection of adrenal tumors – incidentalomas. In most cases, they are non-functioning adenomas of the adrenal cortex, but anyway they may require therapeutic intervention, especially in case of adrenal cortex carcinoma, hormone-producing adenoma, or metastases. In 2023, The European Society of Endocrinology published a revised version of the first international multidisciplinary guideline concerning incidentalomas. The article provides a brief overview of modern approaches to the management of such kind of patients.

Full Text

Restricted Access

About the authors

Sergey B. Shustov

I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia; S.M. Kirov Military Medical Academy of the Ministry of Defence of the Russian Federation

Email: Sergei.Shustov@szgmu.ru
ORCID iD: 0000-0002-9075-8274

MD, Dr. Sci. (Medicine), professor, head of the Center of Adrenal Pathology, I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia. 

Russian Federation, Saint Petersburg; Saint Petersburg

Zulfiya R. Shafigullina

I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia

Email: zulfiya.shafigullina@szgmu.ru
ORCID iD: 0000-0001-8292-8504

MD, PhD (Medicine), associate professor

Russian Federation, Saint Petersburg

Anna N. Vydrych

I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia

Email: anna.vydrych@szgmu.ru
ORCID iD: 0009-0006-9667-3454

MD, PhD (Medicine), endocrinologist 

Russian Federation, Saint Petersburg

Lyudmila I. Velikanova

I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia

Author for correspondence.
Email: velikanova46@gmail.com
ORCID iD: 0000-0002-9352-4035

MD, Dr. Sci. (Biology), professor

Russian Federation, Saint Petersburg

References

  1. Бельцевич Д.Г., Мельниченко Г.А., Кузнецов Н.С. с соавт. Клинические рекомендации Российской ассоциации эндокринологов по дифференциальной диагностике инциденталом надпочечников. Эндокринная хирургия. 2016; 10(4): 31–42. [Beltsevich D.G., Mel’nichenko G.A., Kuznetsov N.S. et al. Russian Association of Endocrinologists clinical practice guideline for adrenal incidentalomas differential diagnosis. Endokrinnaya khirurgiya = Endocrine Surgery. 2016; 10(4): 31–42 (In Russ.)]. https://doi.org/10.14341/serg2016431-42. EDN: YQYUJL.
  2. Cuthbertson D.J., Alam U., Davison A.S. et al. Investigation and assessment of adrenal incidentalomas. Clin Med (Lond). 2023; 23(2): 135–40. https://doi.org/10.7861/clinmed.2023-0042. PMID: 36958837. PMCID: PMC11046519.
  3. Fassnach M., Tsagarakis S., Terzolo M. et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023; 189(1): G1–G42. https://doi.org/10.1003/ejendo/lvad066. PMID: 37318239.
  4. Bancos I., Prete A. Approach to the patient with adrenal incidentaloma. J Clin Endocrinol Metab. 2021; 106(11): 3331–53. https://doi.org/10.1210/clinem/dgab512. PMID: 34260734. PMCID: PMC8530736.
  5. Sherlock M., Scarsbrook A., Abbas A. et al. Adrenal incidentaloma. Endocr Rev. 2020; 41(6): 775–820. https://doi.org/10.1210/endrev/bnaa008. PMID: 32266384. PMCID: PMC7431180.
  6. Sconfienza E., Tetti M., Forestiero V. et al. Prevalence of functioning adrenal incidentalomas: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2023; 108(7): 1813–23. https://doi.org/10.1210/clinem/dgad044. PMID: 36718682.
  7. Calissendorff J., Juhlin C.C., Sundin A. et al. Adrenal myelolipomas. Lancet Diabetes Endocrinol. 2021; 9(11): 767–75. https://doi.org/10.1016/S2213-8587(21)00178-9. PMID: 34450092. PMCID: PMC8851410.
  8. Araujo-Castro M., Nunez M.A.S., Marazuela M. Autonomous cortisol secretion in adrenal incidentalomas. Endocrine. 2019; 64(1): 1–13. https://doi.org/10.1007/s12020-019-01888-y. PMID: 30847651.
  9. Velikanova L.I., Shafigullina Z.R., Lisitsin A.A. et al. Different types of urinary steroid profiling obtained by high-performance liquid chromatography and gas chromatography-mass spectrometry in patients with adrenocortical carcinoma. Horm Cancer. 2016; 7(5–6): 327–35. https://doi.org/10.1007/s12672-016-0267-0. PMID: 27370636. PMCID: PMC10355950.
  10. Kerkhofs T.M.A., Kerstens M.N., Kema I.P. et al. Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors. Horm Cancer. 2015; 6(4): 168–75. https://doi.org/10.1007/s12672-015-0224-3. PMID: 25985881. PMCID: PMC4486399.
  11. Mizdrak M., Kurir T.T., Bozic J. The role of biomarkers in adrenocortical carcinoma: A review of current evidence and future perspectives. Biomedicines. 2021; 9(2): 174. https://doi.org/10.3390/biomedicines9020174. PMID: 33578890. PMCID: PMC7916711.
  12. Hines J.M., Bancos I., Bancos C. et al. High-resolution, accurate-mass (HRAM) mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders. Clin Chem. 2017; 63(12): 1824–35. https://doi.org/10.1373/clinchem.2017.271106. PMID: 28814383.
  13. Bancos I., Taylor A.E., Chortis V. et al.; ENSAT EURINE-ACT Investigators. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: A prospective test validation study. Lancet Diabetes Endocrinol. 2020; 8(9): 773–81. https://doi.org/10.1016/S2213-8587(20)30218-7. PMID: 32711725. PMCID: PMC7447976.
  14. Shafigullina Z.R., Velikanova L.I., Vorokhobina N.V. et al. Urinary steroid profiling by gas chromatography mass spectrometry: Early features of malignancy in patients with adrenal incidentalomas. Steroids. 2018; 135: 31–35. https://doi.org/10.1016/j.steroids.2018.04.006. PMID: 29689248.
  15. Великанова Л.И., Шафигуллина З.Р., Ворохобина Н.В. с соавт. Дифференциальная диагностика инциденталом надпочечников различными лабораторными технологиями. Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2015; 7(4): 52–58. [Velikanova L.I., Shafigullina Z.R., Vorokhobina N.V. et al. Differential diagnostics of adrenocortical incidentalomas with different laboratory technologies. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I.I. Mechnikova = Herald of the North-Western State Medical University named after I.I. Mechnikov. 2015; 7(4): 52–58]. EDN: VJIVZZ.
  16. Eisenhofer G., Masjkur J., Peitzsch M. et al. Plasma steroid metabolome profiling for diagnosis and subtyping patients with Cushing syndrome. Clin Chem. 2018; 64(3): 586–96. https://doi.org/10.1373/clinchem.2017.282582. PMID: 29208661.
  17. Шафигуллина З.Р., Великанова Л.И., Ворохобина Н.В. с соавт. Сочетание классических тестов и методов хроматографии в лабораторной диагностике синдрома Кушинга различного генеза. Клиническая лабораторная диагностика. 2020; 65(7): 418–423. [Shafigullina Z.R., Velikanova L.I., Vorokhobina N.V. et al. The combination of classical tests and methods of chromatography for laboratory diagnostics of cushing’s syndrome of different genesis. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics. 2020; 65(7): 418–423 (In Russ.)]. https://doi.org/10.18821/0869-2084-2020-65-7-418-423. EDN: AMBRSH.
  18. Fassnacht M., Arlt W., Bancos I. et al. Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the study of adrenal tumors. Eur J Endocrinol. 2016; 175(2): G1–G34. https://doi.org/10.1530/eje-16-0467. PMID: 27390021.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bionika Media